Bristol-Myers Squibb CompanyBMYNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P29
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -6.81% |
| 2024 | 9.60% |
| 2023 | 6.08% |
| 2022 | -19.38% |
| 2021 | 15.34% |
| 2020 | 71.16% |
| 2019 | 16.19% |
| 2018 | 33.95% |
| 2017 | 72.50% |
| 2016 | 45.27% |